Merck (MSD) has received approval from the US Food and Drug Administration (FDA) for the subcutaneous format of its best-selling oncology asset, Keytruda. Image credit: U.P.SD via ShutterStock.com.
NSC highlights 10 cutting-edge technologies aimed at reducing musculoskeletal disorders, with MākuSafe named winner of the 2025 Safety Innovation Challenge. The National Safety Council showcased 10 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback